Clinical Updates | February 15, 2021
Date of Presentation: February 15, 2021
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #covid clinical updates #masking #variants
In this presentation, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Services, shares valuable updates on mask guidance as well as COVID-19 testing, treatment, and the latest on mutant variants.
Recording:
Presented by:
Dr. Jorge Mera
Jorge Mera, MD, FACP, is the Director of Infectious Diseases for Cherokee Nation Health Service, the largest tribally operated health care system in the United States. He oversees surveillance, policies, and programs to treat and prevent the transmission of COVID-19, sexually transmitted diseases, HIV and HCV.
Resources Provided:
- Clinical Updates (Presentation Slides)
- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial (JAMA)
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results (NEJM)
- Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2) (Annals of Internal Medicine)
- Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021 (CDC)
- SARS-CoV-2 Variants (WHO)
- Emerging SARS-CoV-2 Variants (CDC)
- mRNA-1273 Vaccine Induces Neutralizing Antibodies Against Spike Mutants from Global SARS-CoV-2 Variants (Pre-print bioRxiv)
- Predictive Power of SARS-CoV-2 Wastewater Surveillance for Diverse Populations Across a Large Geographical Range (Pre-print medRxiv)
- Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture (Clinical Infectious Diseases)
Date added: February 15, 2021